CollPlant Biotechnologies Ltd Revenue from Contract with Customer, Including Assessed Tax
CollPlant Biotechnologies Ltd (CLGN) reported Revenue from Contract with Customer, Including Assessed Tax of $2.37 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-03-26
- CollPlant Biotechnologies Ltd revenue from contract with customer, including assessed tax for the quarter ending 2025-06-30 was $179.00K, a 28.11% decline year-over-year.
- CollPlant Biotechnologies Ltd revenue from contract with customer, including assessed tax for the quarter ending 2024-06-30 was $249.00K, a 97.55% decline year-over-year.
- CollPlant Biotechnologies Ltd revenue from contract with customer, including assessed tax for the quarter ending 2023-06-30 was $10.18M.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|
| 2025-12-31 | $2.37M 20-F · filed 2026-03-26 | ||
| 2025-06-30 | $179.00K 6-K · filed 2025-08-20 | $2.23M 6-K · filed 2025-08-20 | |
| 2024-12-31 | $515.00K 20-F · filed 2026-03-26 | ||
| 2024-06-30 | $249.00K 6-K · filed 2025-08-20 | $347.00K 6-K · filed 2025-08-20 | |
| 2023-12-31 | $10.96M 20-F · filed 2026-03-26 | ||
| 2023-06-30 | $10.18M 6-K · filed 2024-08-20 | $10.62M 6-K · filed 2024-08-20 | |
| 2022-12-31 | $299.00K 20-F · filed 2025-03-26 | ||
| 2021-12-31 | $15.64M 20-F · filed 2024-04-04 |